Company Overview from our Founder

---

Our general business philosophy can be summarized and characterized by the following key points:  

• Niche and specialty drugs - we focus on drugs that are characterized by high transaction value (or prescription value), but lower transaction volumes which have included rare diseases like SCD, thalassemia, and biologic disease modifying therapies, such as in multiple sclerosis, psoriasis, rheumatoid arthritis, and the like.
• Understand the science and behaviours - we are an evidence-based marketing service provider, reviewing and understanding the clinical evidence supporting the brand, it's key messages, competitive set and how, if at all, these factors may influence prescribers.
•  Fewer clients and brands - we have structured our business so as to partner with clients over a multi-year Term from pre-launch through to launch and are able to accomplish this by being small, focused, and customer/brand-centric. This approach results in 1) Diminished need for new business activity, 2) Focus only on certain therapeutic areas and clients at any given time and 3) Fewer brands in the portfolio means we can keep current, have bandwidth
  
•  Migrate value to the client - with fewer clients and brands in the portfolio mean we can develop proactive proposals and concepts, all coupled with a lower overhead model 
• It all starts with our primary offering - turnkey Consultant Meetings, also known as advisory boards, including Investigator Meetings. We help clients in pre-launch through to the first few years of launch / commercial availability. Our offering can include content, logistics, and compliance management with your important KOL customers and influencers.

We have provided equity financing to several healthcare companies, including a privately held Canadian pharmaceutical company with a focus on medical devices for reproductive medicine and a healthcare services company. We are in the process of finalizing our exits from these companies and are looking for our next investment. 

We are presently seeking brands for licensing into Canada directly - these brands would have some of the following characteristics: 

1. Rare disease or niche brand
2. Want to expand the markets your are selling into via Licensing / Distribution Agreement 
3. Want a local to manage regulatory, become the Market Authorization Holder